| Specialty Retail Industry | Consumer Discretionary Sector | Mr. Vimal Dhirendra Shah CEO | MSE Exchange | INE744C01029 ISIN |
| India Country | 33 Employees | - Last Dividend | 22 Aug 2013 Last Split | - IPO Date |
Norris Medicines Limited is a distinguished entity in the Indian pharmaceutical sector, renowned for its dedication to the research and production of medical preparations. Founded in 1990 and headquartered in Ankleshwar, India, the company has carved a niche in the pharmaceutical industry by offering a wide array of medical products and services. With a strong presence in both the domestic and international markets, including exporting to Ukraine, Ghana, and other African countries, Norris Medicines Limited has established itself as a key player in the pharmaceutical manufacturing sector. The company is also recognized for its contract and loan license manufacturing services, catering to the needs of multinational and Indian pharma companies alike.
In addition to these products, Norris Medicines Limited provides contract and loan license manufacturing services, offering its manufacturing expertise to multinational and Indian pharmaceutical companies. This allows the company to produce a vast range of pharmaceutical products under contract, adhering to strict quality standards and regulatory requirements.